FDA could loosen rules on peptides Image By HPN Staff Key Points Health and Human Services Secretary Robert F. Kennedy Jr. said the FDA may soon take action to make peptides more accessible, possibly allowing consumers to obtain them from regulated suppliers. Peptides, which are chains of amino acids linked to benefits for muscle growth, skin health, weight management, and overall wellness, have gained attention through celebrity endorsements, social media influencers, and biohacking communities. The discussion is connected to the Make America Healthy Again movement and reflects a broader policy debate between expanding consumer access to wellness products and ensuring safety through FDA oversight and testing. Health and Human Services Secretary Robert F. Kennedy, Jr., says that the Food and Drug Administration may consider steps to make peptides more accessible to Americans. “I think within a couple of weeks, we will have announced some kind of new action, and my hope is that they’re going to end up with — they’re still looking at the science — my hope is that they’re going to get moved to a place where people have access from ethical suppliers,” Kennedy said. Peptides are chains of molecules called amino acids. They have grown in popularity as supplements marketed for potential benefits to skin, muscle, weight management and overall wellness. Some are injected, while others are taken orally. While some peptides are approved by the FDA — like insulin and GLP-1 — certain compounded combinations have not been approved. Kennedy pointed to the Biden administration’s reclassification of several peptide compounds deemed unsafe. Why it matters Kennedy has repeatedly framed his efforts as an attempt to end what he calls the “FDA’s war” on peptides. Interest in the compounds has surged in part due to celebrity endorsements and social media influencers promoting them as part of high-profile wellness routines. The Make America Healthy Again (MAHA) movement is also raising the profile of peptides. Many of the ideas promoted by MAHA overlap with initiatives supported by Kennedy’s network of associates. Kennedy’s circle includes well-known advocates such as ‘biohacker’ Gary Brecka and functional medicine physician and author Dr. Mark Hyman, who actively market peptide products. The bigger picture The push to expand access to peptides fits into a broader set of health trends associated with the MAHA movement. The movement has drawn attention to ingredient changes in popular drinks, changes to the food pyramid and potential risks from everyday technologies. It reflects growing demand among some consumers for personalized wellness solutions and expanded options beyond FDA-approved treatments. For policymakers, the discussion underscores the tension between regulatory oversight and consumer demand. Advocates argue that broader access to peptides could support wellness innovation, while critics caution that some formulations remain untested and may carry unknown risks. SUGGESTED STORIES FDA chief says most prescription drugs should be sold over the counter Food and Drug Administration Commissioner Marty Makary is calling for a sweeping expansion of over-the-counter drugs, arguing that most medications should not require a prescription unless there is a clear safety risk. Makary said in an interview that prescription dr Read more FDA issues new — and controversial — guidance on fluoride for young children The Food and Drug Administration (FDA) has announced that children under age 3 should not receive ingestible fluoride products, including tablets and drops, marking a significant move in the ongoing national debate over fluoride use. The agency sent notices to four Read more Momentum grows to modernize menopause care as FDA weighs new guidance The Food and Drug Administration (FDA) may soon make changes to what is known as the “black box warning” on hormone replacement therapy (HRT) for women in menopause. Commissioner Dr. Martin Makary recently said the FDA is having “serious discussions” about the warnin Read more
FDA chief says most prescription drugs should be sold over the counter Food and Drug Administration Commissioner Marty Makary is calling for a sweeping expansion of over-the-counter drugs, arguing that most medications should not require a prescription unless there is a clear safety risk. Makary said in an interview that prescription dr Read more
FDA issues new — and controversial — guidance on fluoride for young children The Food and Drug Administration (FDA) has announced that children under age 3 should not receive ingestible fluoride products, including tablets and drops, marking a significant move in the ongoing national debate over fluoride use. The agency sent notices to four Read more
Momentum grows to modernize menopause care as FDA weighs new guidance The Food and Drug Administration (FDA) may soon make changes to what is known as the “black box warning” on hormone replacement therapy (HRT) for women in menopause. Commissioner Dr. Martin Makary recently said the FDA is having “serious discussions” about the warnin Read more
